Metagenomi, Inc. MGX
We take great care to ensure that the data presented and summarized in this overview for Metagenomi, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MGX
Top Purchases
Top Sells
About MGX
Insider Transactions at MGX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 05
2025
|
Brian C. Thomas |
SELL
Open market or private sale
|
Direct |
3,830
-0.15%
|
$3,830
$1.77 P/Share
|
|
Dec 05
2025
|
Pamela Wapnick Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,576
-0.83%
|
$1,576
$1.77 P/Share
|
|
Dec 05
2025
|
Matthew Wein |
SELL
Open market or private sale
|
Direct |
199
-0.17%
|
$199
$1.77 P/Share
|
|
Dec 05
2025
|
Jian Irish Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,602
-0.28%
|
$1,602
$1.77 P/Share
|
|
Dec 01
2025
|
Pamela Wapnick Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+38.64%
|
$120,000
$1.6 P/Share
|
|
Dec 01
2025
|
Jian Irish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
248,500
+18.37%
|
$248,500
$1.6 P/Share
|
|
Dec 01
2025
|
Matthew Wein |
BUY
Grant, award, or other acquisition
|
Direct |
96,000
+45.45%
|
$96,000
$1.6 P/Share
|
|
Sep 05
2025
|
Pamela Wapnick Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,576
-2.19%
|
$1,576
$1.81 P/Share
|
|
Sep 05
2025
|
Brian C. Thomas |
SELL
Open market or private sale
|
Direct |
2,701
-0.11%
|
$2,701
$1.81 P/Share
|
|
Sep 05
2025
|
Jian Irish Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,602
-0.5%
|
$1,602
$1.81 P/Share
|
|
Sep 05
2025
|
Matthew Wein |
SELL
Open market or private sale
|
Direct |
199
-1.02%
|
$199
$1.81 P/Share
|
|
Jun 06
2025
|
Matthew Wein |
SELL
Open market or private sale
|
Direct |
199
-1.18%
|
$199
$1.75 P/Share
|
|
Jun 06
2025
|
Sarah B. Noonberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,239
-4.58%
|
$5,239
$1.75 P/Share
|
|
Jun 06
2025
|
Brian C. Thomas |
SELL
Open market or private sale
|
Direct |
10,785
-0.43%
|
$10,785
$1.75 P/Share
|
|
Jun 06
2025
|
Pamela Wapnick Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,576
-2.14%
|
$1,576
$1.75 P/Share
|
|
Jun 06
2025
|
Jian Irish Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,390
-1.98%
|
$6,390
$1.75 P/Share
|
|
Apr 01
2025
|
Sarah B. Noonberg Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,000
+10.91%
|
-
|
|
Apr 01
2025
|
Matthew Wein |
BUY
Grant, award, or other acquisition
|
Direct |
7,425
+20.02%
|
-
|
|
Apr 01
2025
|
Jian Irish Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+6.67%
|
-
|
|
Apr 01
2025
|
Brian C. Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
32,000
+1.25%
|
-
|
Last 12 Months Summary
Buy / Acquisition
555K
Shares
From
5
Insiders
| Grant, award, or other acquisition | 555K shares |
|---|
Sell / Disposition
40.2K
Shares
From
5
Insiders
| Open market or private sale | 40.2K shares |
|---|